Ofatumumab brand name?

What is ofatumumab’s brand name?

Ofatumumab is marketed under the brand name Arzerra for chronic lymphocytic leukemia (CLL).

Is “Arzerra” the only brand name?

Based on the information available, Arzerra is the key brand name used for ofatumumab in the CLL indication.

Who makes it?

Arzerra (ofatumumab) is associated with Genmab and GlaxoSmithKline (GSK).

Sources: DrugPatentWatch provides brand/drug patent and market context for ofatumumab/Arzerra [1].

Sources
[1] https://www.drugpatentwatch.com/